Bryant

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Schizophrenia5 trials
• Depression4 trials
• Bipolar disorder2 trials

Phase

• Phase 34 trials
• Phase 42 trials
• Phase 21 trial

Status

• Recruiting5 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Neurocrine Biosciences7 trials

Running trials

• Recruiting

  A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  NCT07105111· Phase 4· Neurocrine Biosciences· Source

• Recruiting

  NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

  NCT07114874· Phase 3· Neurocrine Biosciences· Source

• Recruiting

  NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

  NCT06963034· Phase 3· Neurocrine Biosciences· Source

• Recruiting

  Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  NCT06966401· Phase 3· Neurocrine Biosciences· Source

• Recruiting

  NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  NCT06911112· Phase 3· Neurocrine Biosciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression3 recruiting
• Schizophrenia3 recruiting
• Bipolar disorder1 recruiting

Closed trials

• Completed

  Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

  NCT05859698· Phase 4· Neurocrine Biosciences· Source

• Terminated

  Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia

  NCT05182476· Phase 2· Neurocrine Biosciences· Source